Contraceptives - Global Strategic Business Report

The global market for Contraceptives is estimated at US$25.7 Billion in 2023 and is projected to reach US$39.3 Billion by 2030, growing at a CAGR of 6.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Contraceptive use is increasing worldwide, marking a positive shift in global reproductive health. Consumer preferences in the contraceptive market are also shifting towards products that offer additional health benefits beyond pregnancy prevention. For instance, some contraceptive pills are designed to alleviate menstrual-related issues such as heavy bleeding and severe cramps, making them more attractive to users. Furthermore, the rise of e-commerce platforms and telemedicine services is revolutionizing the way contraceptives are accessed and purchased. These digital channels provide greater privacy, convenience, and accessibility, particularly for individuals in remote or underserved areas. As a result, the contraceptive market is expanding to reach a broader audience, contributing to its sustained growth and development.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Contraceptive Drugs segment, which is expected to reach US$26.0 Billion by 2030 with a CAGR of a 6.7%. The Contraceptive Devices segment is also set to grow at 5.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $6.7 Billion in 2023, and China, forecasted to grow at an impressive 9.7% CAGR to reach $9.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Contraceptives Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Contraceptives Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Contraceptives Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Agile Therapeutics, Inc., Allergan plc, Ansell Limited, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 92 Featured):

• Agile Therapeutics, Inc.
• Allergan plc
• Ansell Limited
• Bayer AG
• Church & Dwight Co., Inc.
• CooperSurgical Inc.
• Fuji Latex Co. Ltd.
• Janssen Pharmaceuticals, Inc.
• Karex Berhad
• Mankind Pharma Ltd.
• Okamoto Industries, Inc.
• Pfizer Inc.
• Piramal Enterprises Ltd.
• Reckitt Benckiser Group Plc.
• Sagami Rubber Industries Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• Thai Nippon Rubber Industry Co., Ltd.